94. Primary sclerosing cholangitis
134 clinical trials,   105 drugs   (DrugBank: 37 drugs),   18 drug target genes,   131 drug target pathways
Searched query = "Primary sclerosing cholangitis", "PSC"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT02780752 (ClinicalTrials.gov) | October 2018 | 17/5/2016 | A Study of Oral Hymecromone to Treat Adults With Primary Sclerosing Cholangitis | A Pilot Study of Oral Hymecromone to Treat Adults With Primary Sclerosing Cholangitis | Primary Sclerosing Cholangitis | Drug: hymecromone | Stanford University | NULL | Withdrawn | 18 Years | N/A | All | 0 | Phase 1;Phase 2 | United States |